Training | 2009.08.24
National Translational Medicine Consortium Selects change:healthcare to Enhance Communications, Research
change:healthcare has been chosen by GeneSyn IP Ventures, LLC, a partner of the Keystone Institute for Translational Medicine in Philadelphia, Penn., to support a national translational medicine technology consortium, officials announced today. (PRWeb Aug 24, 2009)
Read the full story at http://www.prweb.com/releases/2009/08/prweb2783524.htm
For more information, please visit
http://www.prweb.com/releases/2009/08/prweb2783524.htm
